A melanin pigment purified from an epidemic strain of Burkholderia cepacia attenuates monocyte respiratory burst activity by scavenging superoxide anion

Infection and Immunity

Volumn 67, Issue 2, 1999, Pages 908-913

  Zughaier, Susu M ^a   Ryley, Henry C ^a   Jackson, Simon K ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 DIETHOXYPHOSPHORYL 5 METHYL 1 PYRROLINE 1 OXIDE; ANTIOXIDANT; BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; MELANIN; OXYGEN; SCAVENGER; UNCLASSIFIED DRUG; XANTHINE; XANTHINE OXIDASE;

ARTICLE; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; ELECTRON SPIN RESONANCE; HUMAN; HUMAN CELL; ION EXCHANGE CHROMATOGRAPHY; PHAGOCYTOSIS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN PURIFICATION; RESPIRATORY BURST; STRAIN DIFFERENCE;

BURKHOLDERIA CEPACIA; ESCHERICHIA COLI; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA;

EID: 0032940150     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.2.908-913.1999     Document Type: Article

References (34)

1. Agodi, A., S. Stefani, C. Corsaro, F. Campanile, S. Gribaldo, and G. Sichel. 1996. Study of melanic pigment of Proteus mirabilis. Res. Microbiol. 147: 167-174.
2. Albrecht, D., and T. W. Jungi. 1993. Luminol-enhanced chemiluminescence induced in peripheral blood-derived human phagocytes: obligatory requirement of myeloperoxidase exocytosis by monocytes. J. Leukocyte Biol. 54: 300-306.
3. Allen, R. C. 1986. Phagocytic leukocyte oxygenation activities and chemiluminescence: a kinetic approach to analysis. Methods Enzymol. 133:449-493.
4. Allen, R. C., R. L. Stjernholm, and R. H. Steele. 1972. Evidence for the generation of (an) electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem. Biophys. Res. Commun. 47:679.
5. Baehner, R. L., and D. G. Nathan. 1967. Leukocyte oxidase: defective activity in chronic granulomatous disease. Science 155:835-836.
6. Brown, R. K., and F. J. Kelly. 1994. Role of free radicals in the pathogenesis of cystic fibrosis. Thorax 49:738-742.
7. Darke, B. M., S. K. Jackson, S. M. Hanna, and J. D. Fox. 1998. Detection of human TNFα mRNA by NASBA. J. Immunol. Methods 212:19-28.
8. DeChatelet, L. R., and P. S. Shirley. 1981. Evaluation of chronic granulomatous disease by a chemiluminescence assay of microlitre quantities of whole blood. Clin. Chem. 27:1739-1741.
9. Demko, C. A., R. C. Stern, and C. F. Doershuk. 1998. Stenotrophomonas maltophilia in cystic fibrosis: incidence and prevalence. Pediatr. Pulmonol. 25:304-308.
10. Denton, M. 1997. Stenotrophomonas maltophilia: an emerging problem in cystic fibrosis patients. Rev. Med. Microbiol. 8:15-19.
11. Elborn, J. S., M. Dodd, J. Maddison, L. E. Nixon, J. Nelson, J. Govan, A. K. Webb, and D. Shale. 1994. Clinical and inflammatory responses in CF patients infected with Pseudomonas aeruginosa and Pseudomonas cepacia. Pediatr. Pulmonol. Suppl. 10:278.
12. Galanos, C., O. Luderitz, and O. Westphal. 1969. A new method for the extraction of R-lipopolysaccharide. Eur. J. Biochem. 9:245-249.
13. Goldman, D. A., and J. D. Klinger. 1986. Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology. J. Pediatr. 108:806-812.
14. Govan, J. R. W., P. H. Brown, J. Maddison, et al. 1993. Evidence of transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 342:15-19.
15. Govan, J. R. W., J. E. Hughes, and P. Vandamme. 1996. Burkholderia cepacia: medical, taxonomic and ecological issues. J. Med. Microbiol. 45:395-407.
16. Govan, J. R. W., and J. W. Nelson. 1992. Microbiology of lung infection in cystic fibrosis. Br. Med. Bull. 48:912-930.
17. Greally, P., M. J. Hussein, A. J. Cook, A. P. Sampson, P. J. Piper, and J. F., Price. 1993. Sputum tumor necrosis factor-α and leukotriene concentrations in cystic fibrosis. Arch. Dis. Child. 68:389-392.
18. Hughes, J. E., J. Stewart, G. R. Barclay, and J. R. W. Govan. 1997. Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia. Infect. Immun. 65:4281-4287.
19. Jonston, R. B., B. B. Keele, Jr., H. P. Misra, Jr., J. E. Lehmeyer, L. S. Werb, R. L. Baehner, and K. V. Rajagopalan. 1975. The role of superoxide anion generation in phagocytic bactericidal activity. J. Clin. Investig. 55:1357-1372.
20. Lancet. 1992. Pseudomonas cepacia - more than a harmless commensal? Lancet 339:1385-1386. (Editorial.)
21. Lipuma, J. J., S. E. Dasen, D. W. Neilson, R. C. Stern, and T. L. Stull. 1990. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 336:527-532.
22. Mahenthiralingam, E., D. A. Simpson, and D. P. Speert. 1997. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J. Clin. Microbiol. 35:808-816.
23. Nelson, J. W., S. L. Butler, D. Krieg, and J. R. W. Govan. 1994. Virulence factors of Burkholderia cepacia. FEMS Immunol. Med. Microbiol. 8:89-98.
24. Ogunnariwo, J., and J. M. T. Hamilton-Millar, 1975. Brown- and red-pigmented Pseudomonas aeruginosa: differentiation between melanin and pyrorubrin. J. Med. Microbiol. 8:199-203.
25. Parton, J., B. M. Darke, and S. K. Jackson. 1998. Priming of the respiratory burst in monocytes: the role of lipopolysaccharide structures and protein kinase C. In Abstract for the 5th Conference of the International Endotoxin Society, Santa Fe, N. Mex.
26. Prince, A. 1986. Antibiotic resistance of Pseudomonas species. J. Pediatr. 108:830-834.
27. Rossi, F., P. Bellavite, A. Dobrina, P. Dri, and G. Zabucchi. 1980. Oxidative metabolism of mononuclear phagocytes, p. 1187-1213. In R. van Furth (ed.), Mononuclear phagocytes: functional aspects. Martinus Nijoff, The Hague, The Netherlands.
28. Roubaud, V., S. Sankarapandi, P. Kuppusamy, P. Tordo, and J. Zweier. 1997. Quantitative measurement of superoxide generation using the spin trap 5-(diethoxyphosphoryl)-5-methyl-1-pyrroline-N-oxide. Anal. Biochem. 247:404-411.
29. Ryley, H. C., L. Millar-Jones, A. Paull, and J. Weeks. 1995. Characterisation of Burkholderia cepacia from cystic fibrosis patients living in Wales by PCR ribotyping. J. Med. Microbiol. 43:436-441.
30. Shaw, D., I. R. Poxton, and J. R. W. Govan. 1995. Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide. FEMS Immunol. Med. Microbiol. 11:99-106.
31. +-. Free Rad. Biol. Med. 11:1-8.
32. + Pseudomonas (Burkholderia) cepacia causing CF center epidemics in North America and Britain. Nat. Med. 1:661-666.
33. Sylvester, F. A., U. S. Sajjan, and J. F. Forstner. 1996. Burkholderia (basonym Pseudomonas) cepacia binding to lipid receptors. Infect. Immun. 64:1420-1425.
34. Zughaier, S. M., H. C. Ryley, and S. K. Jackson. Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes. Infect. Immun., in press.